Salute e Benessere

AMA Approves CPT Codes for Caristo's AI-Powered Heart Disease Risk…

"This is a huge leap forward in the fight against heart disease, and a major validation that AI-powered coronary inflammation analysis belongs in routine care," said Frank Cheng, CEO of Caristo Diagnostics. "With CPT approval, we are laying the foundation for a future where every at-risk American has access to precision risk assessment, moving heart care from late-stage intervention to truly preventive medicine." "This is a huge leap forward in the fight against heart…
PR Newswire
08/04/2025

Brainomix Advances Stroke Care with Landmark FDA Clearance

"This key expansion of our Brainomix 360 platform marks a critical advancement in stroke imaging and reinforces our mission to transform stroke care through cutting-edge technology. Brainomix 360 empowers stroke teams by unlocking real-time, high-precision insights that can help expand patient access to life-changing treatments, including both thrombolysis and mechanical thrombectomy, for use up to 24 hours after stroke onset," said Dr Michalis Papadakis, CEO and Co-Founder at…
PR Newswire
08/04/2025

Gedeon Richter: Cariprazine shows effectiveness in the treatment of mental…

In addition, Richter and Recordati organized a scientific symposium titled "Partial activity, full impact: innovations in schizophrenia treatment", where experts discussed the potential of dopamine receptor partial agonists and the importance of understanding the mechanism of action to differentiate and personalize therapies. In addition, Richter and Recordati organized a scientific symposium titled " Partial activity, full impact: innovations in schizophrenia treatment "…
PR Newswire
08/04/2025

MolecuLight Optimizes Burn Care with Advanced Bacterial Imaging at the American…

"The ability to visualize bacteria in real-time with MolecuLight has far-reaching implications for improving burn wound reconstruction," says Dr. Erik Hanson-Viana. "By providing immediate, actionable information, MolecuLight has led to more precise interventions, ultimately improving reconstructive outcomes. My research also demonstrates the clear advantage of MolecuLight-targeted sampling over traditional methods, and I am thrilled to share these findings with my colleagues at…
PR Newswire
08/04/2025

SHINE and Sumitomo Corporation of Americas Announce Partnership to Expand…

Strengthening Global Supply Chains for Critical Medical Isotopes and Advanced Fusion Applications Strengthening Global Supply Chains for Critical Medical Isotopes and Advanced Fusion Applications This collaboration will focus on establishing reliable supply chains for SHINE's portfolio of products and services, including critical medical isotopes like lutetium-177 and molybdenum-99, neutron imaging for industrial inspection, and advanced materials testing. The agreement also lays the...
PR Newswire
08/04/2025

K-Beauty Pioneer COSRX Launches first-ever 'Euro Supporters' Program in…

"We're thrilled to team up with YESSTYLE to bring COSRX's most-loved and latest innovations directly into the hands of European creators," said a COSRX spokesperson. "This program is more than just a campaign; it's an invitation for collective growth. It represents a meaningful opportunity to empower local voices to shape the COSRX story through the lens of our consumers and to build a truly global skincare community. After all, it's our core belief that the best skincare begins…
PR Newswire
08/04/2025

Xeltis successfully passes evaluation phase for €10million investment from…

Only seven companies, including Xeltis, were successful in securing funding, with Xeltis selected as the only life science company among the cohort. To be selected, companies were required to demonstrate high levels of innovation and technological excellence, the potential for significant market, societal and economic impact, as well as execution capabilities. As part of the award, Xeltis will also receive the STEP Seal which allows access to complementary or alternative funding, in addition to…
PR Newswire
08/04/2025

Sectra's fully managed AI offering extended to include pathology following new…

She continues:"There are several barriers for clinical adoption of AI in healthcare. The distribution agreement with Paige, along with the connected proof-of-concept project we are jointly running with the prominent Swedish healthcare provider Region Skåne, is a good example of how we aim to reduce these barriers and make way for future pathology AI implementations." She continues: "There are several barriers for clinical adoption of AI in healthcare. The distribution agreement…
PR Newswire
08/04/2025

Precision for Medicine Partners with SOPHiA GENETICS to Expand Biopharma…

Through this partnership, Precision for Medicine will leverage the SOPHiA DDMTM Platform's advanced AI-driven algorithms to analyze complex multimodal data, including genomic, radiomic, and clinical data. This capability will allow biopharma companies to identify and target the most appropriate patient populations for clinical trials, accelerating biomarker discovery and improve diagnostic capabilities. This is crucial for precision medicine efforts in oncology, rare diseases, and genetic…
PR Newswire
08/04/2025

Nyxoah Provides Update on FDA Approvable Letter for Genio System

Nyxoah Provides Update on FDA Approvable Letter for Genio SystemExpects to meet final FDA requirements for full PMA approval in the second quarterMont-Saint-Guibert, Belgium – April 8, 2025, 07:00am CET / 1:00am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), which develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today announced an update on the FDA approval process for the Genio system.On March 26,...
Nasdaq GlobeNewswire
08/04/2025

Evolutionary: World's Largest Class Single Crystal Diamond Radiation Detector

Diamonds have ideal physical properties for radiation detection, including high thermal and chemical stability and fast response. Additionally, diamonds are composed of carbon, with an atomic number of six, and are particularly closely equivalent to biological tissue. Diamonds have, therefore, been extensively studied as radiation detectors in the fields of nuclear engineering, nuclear fusion, high-energy physics, and medical applications. Until the 1990s, research relied on selected...
PR Newswire
08/04/2025

Regulatory T-cells (Tregs) Market to Observe Significant Growth by 2034 Owing to…

Key Takeaways from the Regulatory T-cells (Tregs) Market Report Key Takeaways from the Regulatory T-cells (Tregs) Market Report Discover which therapies are expected to grab the Treg-based therapies market share @ Regulatory T-cells (Tregs) Market Report Tregs Market Dynamics The Treg therapy market is an emerging segment within the broader cell therapy and immunotherapy landscape, driven by theincreasing understanding of Tregs' role in immune tolerance and autoimmune disease...
PR Newswire
07/04/2025

Endo to Report First Quarter 2025 Financial Results on May 7, 2025

About EndoEndo is a diversified pharmaceutical company boldly transforming insights into life-enhancing therapies. Our passionate team members collaborate to develop and deliver these essential medicines. Together, we are committed to helping everyone we serve live their best life. Learn more at www.endo.com or connect with us on LinkedIn. About EndoEndo is a diversified pharmaceutical company boldly transforming insights into life-enhancing therapies. Our passionate team members collaborate...
PR Newswire
07/04/2025

Monthly information on share capital and company voting rights

(Article 223-16 of General Regulation of the French financial markets authority) Listing market: Euronext GrowthISIN code: FR0010425595 DateTotal number of shares in the capitalTotal number of voting rights 03/31/2025100,290,07889,046,759For further information on Cellectis, please contact: Media contacts: Pascalyne Wilson, Director, Communications, +33 (0)7 76 99 14 33,[email protected] Patricia Sosa Navarro, Chief of Staff to the...
Nasdaq GlobeNewswire
07/04/2025

Innocan Pharma Broadens Intellectual Property Coverage for its Liposomal CBD…

Following the recently granted patent in India for a prolonged-release pharmaceutical formulation using liposomes to encapsulate CBD, Innocan is actively advancing its efforts to strengthen intellectual property protection across additional Asian markets. China, the second-largest pharmaceutical market in the world, was valued with US $163Bn medicine spending at 2023 (IQVIA). The filing of this divisional application in China reflects the expertise and commitment of the Innocan team and…
PR Newswire
07/04/2025

IBA – ACQUISITION OF OWN SHARES

Immediate Release – April 7 th, 2025 Louvain-la-Neuve, Belgium, April 7 th, 2025 -In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam Applications SA (“IBA”) hereby discloses information in relation to its share buyback program announced on March 24 th, 2025. Under this program, IBA has requested a financial intermediary to repurchase up to 650,000 IBA ordinary shares on its behalf under the terms...
Nasdaq GlobeNewswire
07/04/2025

IBA long-term strategy presented at 2025 Capital Markets Day

Announcement of the appointment of Catherine Vandenborre as CFOLouvain-la-Neuve, Belgium, 07 April, 2025 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, hosted its Capital Markets Day (CMD) today at its headquarters in Louvain-la-Neuve, Belgium, and via live webcast.During the event, Olivier Legrain (CEO), Henri de Romrée (Deputy CEO), and the IBA management team outlined the company's purpose, vision, and strategy to shareholders,...
Nasdaq GlobeNewswire
07/04/2025

Casino Group: Notice to the holders of 'Warrants #1' of Casino…

Notice to the holders of 'Warrants #1'of Casino Guichard-Perrachon Paris, 7 April 2025Casino Guichard-Perrachon (Euronext Paris: CO; ISIN: FR001400OKR3) hereby gives notice to the holders of 'Warrants #1' (ISIN: FR001400OJ72) issued on 27 March 2024 (the 'Issue Date') that the exercise price was increased from €0.0461 per warrant #1 to €0.0517 per warrant #1 on 27 March 2025, the first anniversary of the Issue Date.This adjustment is in accordance with the stipulations set out in...
Nasdaq GlobeNewswire
07/04/2025

Canada Leads: Canada's No. 1 Hospital Announces Strategy to Attract World's Most…

"Attracting and retaining the best scientists and entrepreneurs is critical to the future economic growth of Ontario and Canada," said Mr. Dean Connor, Chair of the UHN Board of Trustees. "Canada Leads is designed to accelerate the rapid development of a powerful science-based economy that will translate into world-leading discoveries, protect Canada's universal health system and create exponential economic spin-off in manufacturing, biotech and commercialization."…
PR Newswire
07/04/2025

Global Smart Toilet Market Poised for Rapid Growth, Projected to Reach USD 28.4…

Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=253141 Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=253141 202 - Pages 126 – Tables 37 – Figures Scope Of The Report Smart Toilet Market Overview The increasing emphasis on hygiene and convenience is driving the demand for smart toilets. These advanced sanitation systems offer features such as automatic flushing, bidet functions, seat heating,...
PR Newswire
07/04/2025

US Single-Cell Analysis Market worth US$2,695.3 million by 2029 with 14.3% CAGR…

Browse in-depth TOC on "US Single-Cell Analysis Market" Browse in-depth TOC on "US Single-Cell Analysis Market" 150 - Tables 50 - Figures By Based on Product,the US single-cell analysis market is segmented into consumables and instruments. The consumables segment is further divided into reagents, assay kits, beads, microplate, and other consumables. The instruments segment is further segmented into next-generation sequencing, microscopy, flow cytometry, polymerase chain...
PR Newswire
07/04/2025

ON WORLD HEALTH DAY, MOODY LAUNCHES FIRST-EVER APP MODE TACKLING PREGNANCY LOSS…

LONDON, April 7, 2025 /PRNewswire/ -- LONDON , April 7, 2025 /PRNewswire/ -- Moody's New Mode Changes the Game The new Pregnancy, Postpartum & Loss mode in Moody supports women with: AVAILABLE FOR COMMENT -Amy Thomson, CEO of Moody, says: "I'd never experienced deep depression—until I faced pregnancy loss. It was a harsh awakening to how desperately we need more conversations and resources. This World Health Day theme of healthy beginnings and hopeful futures supports...
PR Newswire
07/04/2025

Teva and Samsung Bioepis Announce Biosimilar EPYSQLI® (eculizumab-aagh)…

EPYSQLI ®(eculizumab-aagh) is now available to patients living with difficult-to-treat rare diseases like paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome and generalized myasthenia gravis in adults who are anti-acetylcholine receptor antibody positiveEPYSQLI will be available at a 30% discount of the Wholesale Acquisition Cost (WAC) of the reference product, Soliris ®(eculizumab), making it one of the greatest cost-saving biosimilars to Soliris ®in the U...
Nasdaq GlobeNewswire
07/04/2025

Gift of Life Biologics and Cellex Cell Professionals GmbH Celebrate Successful…

Since the initiation of the collaboration in 2022, Gift of Life Biologics has consistently delivered customized starting materials that perfectly align with the high-complex donor requirements to Cellex Cell Professionals. These high-quality materials serve as a crucial base for Cellex's production process, ensuring the manufacturing of cutting-edge CGT products that meet regulatory standards and patient needs. "We are thrilled with the progress we have made with Gift of Life...
PR Newswire
07/04/2025
Altri  Comunicati